This website uses cookies to deliver to you the best experience possible on SITC CONNECT. By continuing to use this site, you are providing to us your consent to ensure you receive such an experience.
View our privacy policy to learn more.
OK
Search Options
Join SITC
Renew
Make a Gift
Skip to main content (Press Enter).
Sign in
Skip auxiliary navigation (Press Enter).
Subscribe
Skip main navigation (Press Enter).
Toggle navigation
Educational & Scientific Programs
ConnectED
Advances in Cancer Immunotherapy™
Collaborative Education Programs
2023 Spring Scientific
Workshops
Tumor Immune Microenvironment: A Holistic Approach
Surfaceome Virtual Workshop
Bispecific T cell Engagers Virtual Workshop
Cytokines in Cancer Immunotherapy Virtual Workshop
Call for Proposals
Annual Meeting & Pre-Conference Programs
37th Annual Meeting & Pre-Conference Programs
Past and Future Annual Meetings & Pre-Conference Programs
Cancer Immunotherapy Winter School
Patient and Survivor Education and Resources
Webinars and Online Education
ACI Online Interactive Courses
Advances in Cancer Immunotherapy (ACI) Webinars
Meet-the-Expert Webinars
SITC Clinical Practice Guidelines Online Education
SITC-NCI Computational IO Series
Targets for Cancer IO: A Deep Dive Series
Calendar of Events
Professional Development & Training
Certificate in Cancer Immunotherapy
Meet-the-Expert Program
Meet-the-Expert Webinars
NCI Immunotherapy Fellowship
SITC Sparkathon
SITC Sparkathon 2.0 Accelerator
Support Sparkathon
Other Resources
Calendar of Events
Path to SITC Leadership
Clinical Trials Training and Resources
SITC Clinical Immuno-Oncology Network (SCION) Workshop
Maximizing the Value of Phase III Trials in Immuno-Oncology
Professional Interest Communities
Fellowships
Women in Cancer Immunotherapy Network (WIN)
Women in Cancer Immunotherapy Network 2022
Women in SITC Community
Early Career Scientist (ECS) Committee
Publications & Guidelines
Journal for ImmunoTherapy of Cancer
About JITC
Become a Reviewer
For Authors
From the Editors
JITC Collections and Special Issues
SITC Immunotherapy Books
SITC's Guide to Managing Immunotherapy Toxicity Textbook
Cancer Immunotherapy Principles and Practice Textbook, 2nd Ed.
SITC Clinical Practice Guidelines
Clinical Practice Guidelines
Clinical Practice Guidelines Online Education
Clinical Practice Guidelines Mobile App
Patient Resource Guides
Policy & Advocacy
Advocacy
Crisis in Clinical Research
Global Immunotherapy Access
Government Relations
Quality and Value
Patient & Survivor Education & Resources
Membership
Academy of Immuno-Oncology
About the Academy
Nomination and Selection
Members Only
SITC Member Directory
Renew Your Membership
Become a SITC Member
Membership Benefits
Submit an Application
Membership Categories
Volunteer
Volunteer with SITC
Connect-a-Colleague
Corporate Membership
Path to SITC Leadership
Support SITC
The Forward Fund
Moving the Field Forward
Making a Difference
Named Funds and Awards
Early Career Scientist Awards
Richard V. Smalley Memorial Award and Lectureship
Steven A. Rosenberg Scholars Award
Technology Awards
Martin "Mac" Cheever Travel Award Fund
Sparkathon 2.0 Accelerator
The CheckPoints: SITC’s House Band
Ways to Make a Gift
Donate
Stocks and Securities
Estate and Planned Gifts
Corporate Support and Giving Opportunities
Corporate Giving Opportunities
Corporate Membership
Educational Grants
Sponsorship & Advertising
SITC Merchandise
Honor and Memorial Gifts
Make a Gift in Honor of a Loved One
Make a Gift in Memory of a Loved One
Our Donors and Supporters
2022 SITC Supporters
Forward
Fund Donors
About SITC
Awards and Recognition
Committees, Task Forces and Professional Interest Communities
Partnerships
SITC Policies
Board of Directors
Elevating a Rich Oncology Community: SITC’s DEI Strategic Plan
Media Room
SITC Press Releases
Scientific Meeting Highlights from SITC
Immune Monitor Archive
JITC Digest Archive
Cancer Immunotherapy Month
Career Connections
Mission & Vision
Contact SITC
SITC Staff
Contact Us
The Connect Community
Create Account
My Profile
My Communities
My Libraries
The Sentinel - SITC Blog
2018 SITC Press Releases
Press Release Headline – Date Published
Oncology News Burst from FDA: Pembrolizumab
– 12/19/18
Oncology News Burst from FDA: Atezolizumab
– 12/7/18
Oncology News Burst from FDA: Truxima
– 11/28/18
Oncology News Burst from FDA: Venetoclax
– 11/23/18
Oncology News Burst from FDA: Brentuximab Vedotin
– 11/20/18
Oncology News Burst from FDA: Pembrolizumab
– 11/13/18
Next Generation of Cancer Immunotherapy Primed for Introduction at the 33
rd
Annual Meeting of the Society for Immunotherapy of Cancer
– 11/1/18
Oncology News Burst from FDA: Pembrolizumab
– 10/31/18
Society for Immunotherapy of Cancer to Host 5-Day, Intensive Educational Program for Early Career Scientists and Clinicians
– 10/19/18
Society for Immunotherapy of Cancer Announces Co-Sponsored Workshop with U.S. Food and Drug Administration on Immune-modified Response Criteria in Cancer Immunotherapy Clinical Trials
– 10/12/18
Society for Immunotherapy of Cancer (SITC) Congratulates 2018 Nobel Laureates, Past SITC Smalley Award Recipients, James P. Allison, PhD, and Tasuku Honjo, MD, PhD
– 10/1/18
Oncology News Burst from FDA: Cemiplimab-rwlc
–
10/1/18
Society for Immunotherapy of Cancer Partners with Bonnie J. Addario Lung Cancer Foundation to Increase Participation in the Lung Cancer Registry
– 9/26/18
Oncology News Burst from FDA: Moxetumomab Pasudotox-tdfk
– 9/13/18
Society for Immunotherapy of Cancer Launches Convergence Fellowship Awards in New Collaboration with Stand Up To Cancer
– 8/24/18
Oncology News Alert from FDA: Pembrolizumab and Atezolizumab
– 8/22/18
Oncology News Burst from FDA: Pembrolizumab
- 8/20/18
Oncology News Burst from FDA: Nivolumab
– 8/20/18
Oncology News Burst from FDA: Mogamulizumab
– 8/8/18
Society for Immunotherapy of Cancer Publishes First Clinical Immunotherapy Treatment Guidelines for Non-Small Cell Lung Cancer
– 7/17/18
Society for Immunotherapy of Cancer (SITC) Announces 2018 Recipients of Postdoctoral Cancer Immunotherapy Fellowship Awards
– 7/12/18
Oncology News Burst from FDA: Ipilimumab and Nivolumab
– 7/11/18
Journal for ImmunoTherapy of Cancer
Receives First Impact Factor
– 6/26/18
Oncology News Burst from FDA: Pembrolizumab
– 6/13/18
Oncology News Burst from FDA: Pembrolizumab
– 6/12/18
The Society for Immunotherapy of Cancer (SITC) Highlights Cancer Immunotherapy during Cancer Immunotherapy Month
TM
– 6/1/18
Society for Immunotherapy of Cancer (SITC) Updates its Clinical Immunotherapy Treatment Guidelines for Cutaneous Melanoma
– 5/30/18
Luminaries in Cancer Immunotherapy to Support Research Opportunities for Early Career Scientists in Chicago Rock Concert
– 5/22/18
The Society for Immunotherapy of Cancer now Accepting Applications for 2018 SITC Sparkathon Program
– 5/21/18
Society for Immunotherapy of Cancer (SITC)-Led Study Demonstrating Prognostic Power of “Immunoscore” Published in
The Lancet
– 5/10/18
The Society for Immunotherapy of Cancer Highlights Immunotherapy on Melanoma Monday
– 5/7/18
Oncology News Burst from FDA: Tisagenlecleucel
– 5/3/18
The Society for Immunotherapy of Cancer Announces New Partnerships with the Bonnie J. Addario Lung Cancer Foundation, the Cancer Support Community and Fight Colorectal Cancer
– 4/24/18
Oncology News Burst from FDA: Nivolumab and Ipilimumab
– 4/16/18
The Society for Immunotherapy of Cancer Highlights Immunotherapy During Oral, Head and Neck Cancer Awareness Week
– 4/10/18
Leading Researchers in Cancer Immunotherapy and Biosciences to Collaborate in Novel Two-Day Workshops Hosted by the Society for Immunotherapy of Cancer
– 4/5/18
Oncology News Burst from FDA: Blinatumomab
– 3/29/18
Society for Immunotherapy of Cancer Announces 2018 Recipient of the Richard V. Smalley, MD, Memorial Award and Lectureship
– 3/22/18
Oncology News Burst from FDA: Brentuximab Vedotin
– 3/21/18
Oncology News Burst from FDA: Durvalumab
– 2/16/18
The Society for Immunotherapy of Cancer Supports Scientific Research in New Collaboration with Stand Up To Cancer
– 1/30/18
Return to SITC Press Releases home
Membership Links
Join
Renew
Member Directory
My Profile
Get Involved
Email Sign-up
Volunteer
Support SITC
Contact Us
© 2022 Society for Immunotherapy of Cancer (SITC). All rights reserved.
Powered by Higher Logic